Study to Compare the Safety and Efficacy of Sirolimus (Rapamune) to Tacrolimus (Advagraf) Associated to Mycophenolate Mofetil (CellCept) Between 12 and 36 Months After Kidney Transplantation

NCT00811915 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

65

Enrollment

OTHER

Sponsor class

Stopped Difficulty in enrolling new patients

Conditions

Kidney Transplantation

Interventions

DRUG: Sirolimus

Sponsor

University Hospital, Rouen